Last updated: 2026-09-27 17:30:01. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
AstraZeneca PLC (AZN) operates in the -- sector and is listed on NYSE. The stock is currently priced at $166.58, with a market capitalization of $258.35B and a P/E ratio of 116.32. Over the past 52 weeks, its price has ranged from $147.37 to $212.71. This page covers its latest market performance, valuation, price trends and company information.
$258.35B | |
$166.16 | |
$212.71 | |
$29.96 | |
$164.56 | |
1.80M | |
3.38M | |
116.32 | |
$212.71 | |
$147.37 | |
1.37% | |
-- |
AstraZeneca PLC (AZN) last closed at $164.56 as of 2026-09-25 23:51:00, unchanged from the previous close of $164.56.
During the latest regular trading session, AZN traded between $29.96 and $212.71, with a volume of 1.80M shares. The closing price was near the upper end and near the lower end of its 52-week range.
Over the past seven days, AstraZeneca PLC (AZN) moved from $166.14 to $166.58, representing a gain of 0.27% ($0.44).
The stock traded between $162.91 and $169.35 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 2.82 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 29.4%
AZN is currently trading at $166.58, placing it 29.4% of the way from its 52-week low of $147.37 to its 52-week high of $212.71. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
| Employees | 96100 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of AstraZeneca PLC (AZN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.